Author

M. Cartwright

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

D. E. Ingber· 2 shared M. Super· 2 shared A. Burgener· 1 shared A. C. Collier· 1 shared A. Geirnaert· 1 shared A. L. M. Dinis· 1 shared A. R. Berard· 1 shared A. Sontheimer-Phelps· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

D. E. Ingber

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection

S. M. Hughes, C. N. Levy, F. Calienes, J. D. Stekler, U. Pandey, L. Vojtech, A. R. Berard, K. Birse, L. Noel-Romas, B. Richardson, J. B. Golden, M. Cartwright, A. C. Collier, C. E. Stevens, M. E. Curlin, , F. Hladik

This study shows that oral TDF/FTC antiretroviral drugs induce a type I/III interferon signature in the gut without HIV infection, potentially affecting immune responses.

bioRxiv · Aug 3, 2020Immunology

Species-specific enhancement of enterohemorrhagic E. Coli pathogenesis mediated by microbiome metabolites

A. Tovaglieri, A. Sontheimer-Phelps, A. Geirnaert, R. Prantil-Baun, D. M. Camacho, D. B. Chou, S. Jalili-Firoozinezhad, T. de Wouters, M. Kasendra, M. Super, M. Cartwright, C. A. Richmond, D. T. Breault, C. Lacroix, D. E. Ingber

The paper identifies human gut microbiome metabolites that enhance EHEC pathogenesis in a human colonic organ chip model, contributing to species-specific susceptibility.

bioRxiv · Jan 7, 2019Bioengineering

Broad spectrum capture of clinical pathogens using engineered Fc-Mannose-Binding Lectin (FcMBL) enhanced by antibiotic treatment

B. T. Seiler, M. Cartwright, A. L. M. Dinis, S. Duffy, P. Lombardo, D. Cartwright, E. H. Super, J. Lanzaro, K. Dugas, M. Super, D. E. Ingber

This study demonstrates that FcMBL binds to 86% of pathogen isolates and 90% of pathogen species, including bacteria, fungi, viruses, and parasites, and antibiotic treatment enhances its binding efficiency.

bioRxiv · Aug 8, 2018Immunology